Related Experiment Video
Updated: Aug 8, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
[Effect of protein kinase C on human melanoma A375-S2 cell death induced by evodiamine]
Che Wang1, Min-wei Wang, Shin-ichi Tashiro
1China-Japan Research Institute of Medical and Pharmaceutical Sciences.
Aim:
To study the role of PKC in evodiamine-induced A375-S2 cell death.
Methods:
Ratio of apoptosis induced by evodiamine was determined by TUNEL assay. MTT assay was carried out to assess cytotoxic effect of evodiamine. The influence on expression of ERK, phospho-ERK and Bcl-2 was detected by Western blotting analysis.
Results:
TUNEL assay indicated that apoptosis was the type of A375-S2 cell death induced by evodiamine treatment for 24 h. Both staurosporine (inhibitor of PKC) and PD98059 (inhibitor of ERK) cooperated with evodiamine to further induce A375-S2 cell death. Evodiamine inhibited PKC activity, down-regulated the expression of ERK, phospho-ERK and Bcl-2, and staurosporine was capable of augmenting these effects induced by evodiamine.
Conclusion:
PKC lies upstream and exhibits regulatory effect on ERK and Bcl-2 in evodiamine-induced cell death.
Insights
Evodiamine induces apoptosis in A375-S2 cells by inhibiting protein kinase C (PKC), which regulates ERK and Bcl-2 expression, leading to cell death.
Area of Science:
- Molecular Biology
- Cell Biology
- Pharmacology
Background:
- Evodiamine is a natural compound with potential anti-cancer properties.
- Understanding the molecular mechanisms of evodiamine's action is crucial for its therapeutic development.
Purpose of the Study:
- To investigate the role of protein kinase C (PKC) in evodiamine-induced apoptosis of A375-S2 cells.
- To elucidate the relationship between PKC, ERK, and Bcl-2 in this process.
Main Methods:
- TUNEL assay to quantify apoptosis.
- MTT assay for cytotoxic effect assessment.
- Western blotting to analyze protein expression (ERK, phospho-ERK, Bcl-2).
Main Results:
- Evodiamine treatment induced apoptosis in A375-S2 cells.
- PKC inhibition (staurosporine) and ERK inhibition (PD98059) enhanced evodiamine-induced cell death.
- Evodiamine inhibited PKC activity and down-regulated ERK, phospho-ERK, and Bcl-2 expression.
Conclusions:
- PKC acts upstream of ERK and Bcl-2 in the evodiamine-induced cell death pathway.
- These findings highlight PKC as a key mediator in evodiamine's anti-cancer effects.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Intrinsic Apoptotic Pathway
Cytotoxic Edema: Pathophysiology

